Chatterton & Associates’s CVS Health CVS Stock Holding History

Chatterton & Associates’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$219K	Buy	+2,134	New	+$190K	0.13%	98

Other funds holding CVS

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Chatterton & Associates's CVS Position: Q2 2026 in Review

Chatterton & Associates opened a new position in CVS Health (CVS) in Q2 2026: 2,134 shares worth $219K. The stake represents 0.13% of the portfolio and ranks #98 among its holdings.

1,190 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

Chatterton & Associates held 2,134 shares of CVS Health worth $219K as of Q2 2026.
CVS Health was a new Chatterton & Associates position in Q2 2026.
CVS Health made up 0.13% of Chatterton & Associates's portfolio in Q2 2026, its #98 holding.
1,190 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Chatterton & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.